In vivo imaging of islet transplantation using PLGA nanoparticles containing iron oxide and indocyanine green
暂无分享,去创建一个
Jung Hwan Hwang | Bong Hyun Chung | Kwan Soo Hong | Yong Taik Lim | Jung-Ran Noh | K. Hong | J. Hwang | Gil-Tae Gang | Chul-Ho Lee | Yong-Hoon Kim | Jung-Ran Noh | Y. Lim | Hee Gu Lee | Hye Sun Park | Young-Woock Noh | Hyeyoung Moon | Young‐Woock Noh | Jung-Hyun Choi | Yong-Hoon Kim | Gil-Tae Gang | Kyoung-Shim Kim | Chul-Ho Lee | H. Park | H. Moon | Kyoung-Shim Kim | B. H. Chung | J. Choi | Hee Gu Lee
[1] C. Bailey,et al. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice , 1990, Diabetologia.
[2] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .
[3] Atle Bjørnerud,et al. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system , 2004, NMR in biomedicine.
[4] K. Ahn,et al. Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response. , 2011, Biomaterials.
[5] D. Jirák,et al. Magnetic resonance imaging of intrahepatically transplanted islets using paramagnetic beads. , 2005, Transplantation proceedings.
[6] Anna Moore,et al. In vivo imaging of islet transplantation , 2006, Nature Medicine.
[7] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[8] A. Secchi,et al. Islet-cell Transplantation , 1975, The Lancet.
[9] Habib Zaidi,et al. Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. , 2005, Transplantation.
[10] C. Ricordi,et al. Edmonton's islet success has indeed been replicated elsewhere , 2003, The Lancet.
[11] Vishal Saxena,et al. Degradation kinetics of indocyanine green in aqueous solution. , 2003, Journal of pharmaceutical sciences.
[12] A. F. Stewart,et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. , 2001, Diabetes.
[13] R. Brentjens,et al. Islet cell tumors of the pancreas: the medical oncologist's perspective. , 2001, The Surgical clinics of North America.
[14] H. Broman,et al. The application of the Prussian blue stain to previously stained films of blood and bone marrow. , 1955, Blood.
[15] Deren Yang,et al. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging , 2009, Nanotechnology.
[16] Anders M. Dale,et al. Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy , 2004, NeuroImage.
[17] P. Cooper. What will reorganisation do for the patient , 1974 .
[18] Sue-N. Park,et al. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. , 2009, Toxicology and applied pharmacology.
[19] Anna Moore,et al. In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets , 2006, Diabetes.
[20] G. Dai,et al. In vivo multimodal imaging of transplanted pancreatic islets , 2006, Nature Protocols.
[21] A. M. James Shapiro,et al. TOWARD DEVELOPMENT OF IMAGING MODALITIES FOR ISLETS AFTER TRANSPLANTATION: INSIGHTS FROM THE NATIONAL INSTITUTES OF HEALTH WORKSHOP ON BETA CELL IMAGING , 2004, Transplantation.
[22] J. T. Cox,et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors , 2007, CA: a cancer journal for clinicians.
[23] J. Gearhart,et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.
[24] C. Newgard,et al. STZ Transport and Cytotoxicity: Specific Enhancement in GLUT2-Expressing Cells , 1994, Diabetes.
[25] C. Ricordi,et al. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. , 1998, Diabetes.
[26] Francesco Muntoni,et al. Muscle MRI in inherited neuromuscular disorders: Past, present, and future , 2007, Journal of magnetic resonance imaging : JMRI.
[27] A. Cudworth. Type I diabetes mellitus , 1978, Diabetologia.
[28] C. Colyer,et al. Non-covalent labeling of human serum albumin with indocyanine green: a study by capillary electrophoresis with diode laser-induced fluorescence detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[29] E. Rummeny,et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. , 2005, Radiology.
[30] C. Mathieu,et al. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. , 2000, Diabetes.
[31] Ron C. Hardman. A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.
[32] Bong Hyun Chung,et al. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. , 2008, Small.
[33] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[34] Piotr Walczak,et al. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. , 2011, Contrast media & molecular imaging.
[35] S. Hussain,et al. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.
[36] Y. Le Marchand-Brustel,et al. Effect of fasting and streptozotocin diabetes on insulin binding and action in the isolated mouse soleus muscle. , 1979, The Journal of clinical investigation.
[37] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[38] B. Chung,et al. Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. , 2012, Toxicology.
[39] A. Di Carlo,et al. Hepatic Sinusoidal Endothelium Upregulates IL-1α, IFN-γ, and iNOS in Response to Discordant Xenogeneic Islets in an in Vitro Model of Xenoislet Transplantation , 2002 .
[40] E. Morrison,et al. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats. , 1996, The West Indian medical journal.
[41] L. Opie,et al. Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. , 1968, Lancet.
[42] J. Gaglia,et al. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. , 2003, Diabetes care.